Towards a rational treatment of essential thrombocythemia, despite limited evidence and old prejudices.
Cazzola
Mario
M
University of Pavia Medical School, Division of Hematology, IRCCS Policlinico S. Matteo, 27100 Pavia, Italy. mario. cazzola@unipv. it
D000328:Adult; D015331:Cohort Studies; D018450:Disease Progression; D019317:Evidence-Based Medicine; D005104:Expert Testimony; D005260:Female; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects / Q000627:therapeutic use; D007951:Leukemia, Myeloid / Q000139:chemically induced / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D011379:Prognosis; D013920:Thrombocythemia, Essential / Q000150:complications / Q000628:therapy*; D013923:Thromboembolism / Q000517:prevention & control
D006918:Hydroxyurea